Showing results (431-440 of 462) with videos related to

Sort By:
Pageof 47
Trials|May 26, 2021
The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomizationDavid T Huang, Erin K McCreary, J Ryan Bariola, et al.
Critical Care Medicine|February 16, 2021
Sepsis Subclasses: A Framework for Development and InterpretationKimberley M DeMerle, Derek C Angus, J Kenneth Baillie, et al.
Intensive Care Medicine|April 7, 2026
Innovation in intensive care: a framework to turn ideas and concepts into actionable solutionsMaurizio Cecconi, Massimiliano Greco, Eleonora Balzani, et al.
Annals of the American Thoracic Society|April 9, 2020
The REMAP-CAP (Randomized Embedded Multifactorial Adaptive Platform for Community-acquired Pneumonia) Study. Rationale and DesignDerek C Angus, Scott Berry, Roger J Lewis, et al.
JAMA|May 26, 2018
Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income CountriesKristina E Rudd, Christopher W Seymour, Adam R Aluisio, et al.
Intensive Care Medicine|March 29, 2017
Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the futureMarcus J Schultz, Martin W Dunser, Arjen M Dondorp, et al.
JAMA|October 3, 2019
Effect of Selepressin vs Placebo on Ventilator- and Vasopressor-Free Days in Patients With Septic Shock: The SEPSIS-ACT Randomized Clinical TrialPierre-Francois Laterre, Scott M Berry, Allan Blemings, et al.
JAMA|September 3, 2020
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis, Jonathan A C Sterne, Srinivas Murthy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 18, 2022
Prospective Evaluation of Coronavirus Disease 2019 (COVID-19) Vaccine Responses Across a Broad Spectrum of Immunocompromising Conditions: the COVID-19 Vaccination in the Immunocompromised Study (COVICS)Ghady Haidar, Mounzer Agha, Andrew Bilderback, et al.
Contemporary Clinical Trials|June 13, 2022
The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trialErin K McCreary, J Ryan Bariola, Tami E Minnier, et al.
Pageof 47